Nitazenes present an emerging synthetic opioid threat for healthcare professionals
Nitazenes are highly potent synthetic opioids from the benzimidazole family that now present a fast-moving threat in the United Kingdom and in other regions. The core scaffold places them apart from natural opiates such as morphine and from other synthetic drugs such as fentanyl. Their return to illicit markets since 2019 has aligned with clusters […]